The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers and autoinjectors, in an effort to increase competition and potentially lower some prices.

Anthem Blue Cross and Blue Shield in Nevada (Anthem) recently earned the National Committee for Quality Assurance (NCQA) Health Equity Accreditation Plus, a recognition of Anthem’s leadership in developing solutions to enhance access to equitable, high-quality healthcare in Nevada.

Health care affordability is worsening in California, with health care costs rising significantly faster than household income, and more than half of the state’s residents saying they or a family member skipped or delayed care in the past year because of cost.

When Kristy Uddin, 49, went in for her annual mammogram last year, she assumed she would not incur a bill because the test is one of the many preventive measures guaranteed to be free to patients under the 2010 Affordable Care Act.

 Pharmaceutical companies are due to receive by Thursday the U.S. government's opening proposal for what are expected to be significant discounts on 10 of its high-cost medicines, an important step in the Medicare health program's first ever price negotiations.

The CEOs of Merck and Johnson & Johnson have voluntarily agreed to testify at an upcoming Senate hearing on high drug prices in the U.S., Sen. Bernie Sanders announced Friday, as lawmakers ramp up efforts to rein in health-care costs for Americans.